Form 4 for RMD ResMed|
Accepted 2021-11-18 00:00:00 ET · period of report 2021-11-16 · accession 0001127602-21-029587 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-11-18 | 2021-11-16+ | RMD | Farrell Michael J. | CEO | A - Grant | $239.77 | +75.7K | 487.2K | +18% | +$18.16M |
| 2021-11-18 | 2021-11-19 | RMD | Farrell Michael J. | CEO | G - Gift | $0.00 | -44.2K | 405.2K | -10% | $0 | |
| 2021-11-18 | 2021-11-17 | RMD | Farrell Michael J. | CEO | F - Tax | $254.81 | -42.2K | 445.0K | -9% | -$10.76M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2021-11-18 | A | A | 4,469 | $0.00 | 449,479 | D | — | — | |
| 2 | Common | ResMed Common Stock | 2021-11-19 | G | D | 44,250 | $0.00 | 405,229 | D | — | — | |
| 3 | Common | ResMed Common Stock | 2021-11-17 | F | D | 42,210 | $254.81 | 445,010 | D | — | — | |
| 4 | Common | ResMed Common Stock | 2021-11-16 | A | A | 71,262 | $254.81 | 487,220 | D | — | — |